RECHERCHE :   Cancers du poumon - cancers thoraciques
Filtrage ? Le champ de filtrage permet de trier les études comportant le mot saisie. La recherche du mot se fait uniquement dans le contenu texte affiché à l'écran.
ETUDE PHASE SITE
AMGEN 20160323: A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of AMG 757 in Subjects With Small Cell Lung Cancer
cancer du poumon à petites cellules
I
CHUV
IOSI-LUNG-001: Atezolizumab plus 8 Gy single-fraction radiotherapy for advanced, oligoprogressive NSCLC after upfront chemotherapy and anti-PD1 immunotherapy: A multicentre, single arm, phase II study
Advanced and oligoprogressive NSCLC
II
HUG
CHUV-DO-0022-LUNGVAC-2019: Phase Ib study to test the feasibility and safety of a personalized vaccine in combination with low-dose cyclophosphamide in patients with advanced or metastatic NSCLC
NSCLC avancé ou métastatique
I
CHUV
MK3475-867: A Phase 3, Randomized, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Stereotactic Body Radiotherapy (SBRT) with or without Pembrolizumab (MK-3475) in Participants with Medically Inoperable Stages I or IIA Non Small Cell Lung Cancer (NSCLC) (KEYNOTE-867)
Medically inoperable NSCLC Stages I and IIA
III
HUG
CHUV-DO-0018-NeoTIL-2019: Pilot Study to Assess the Feasibility, Safety and Efficacy of Adoptive Transfer of Autologous Tumor-Infiltrating Lymphocytes Enriched for Tumor Antigen Specificity (NeoTIL) in Advanced Solid Tumors.
Tumeurs solides
I
CHUV
SAKK16/18: Immune-modulatory radiotherapy to enhance the effects of neoadjuvant PD-L1 blockade after neoadjuvant chemotherapy in patients with resectable stage III(N2) NSCLC. A multicenter phase II trial.
resectable stage III(N2) NSCLC
II
HUG
SGNB6A-001: A Phase 1 Study of SGN-B6A in Advanced Solid Tumors
NSCLC, HNSCC, ESCC, HGSOC, cSCC, cancer du sein HER2 négative avancé, Adénocarcinome oesophagien/adénocarci-nome gastro-oesophagien, cancer de la vessie, cancer degestif, cancer du col de l'utérus
I
CHUV